To do so, we followed an experimental strategy: first, we measured CD25 and CD137 expression on NK cells after brief stimulation with cytokines, and then we activated NK cells with tumor cells after a 6-day rest (Fig. 2A). The gene discussed is TNFRSF9; the disease is neoplasm.